UK markets closed

SENS Jul 2023 1.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.3200+0.0100 (+3.23%)
At close: 03:30PM EST
Full screen
Previous close0.3100
Open0.3200
Bid0.2300
Ask0.5200
Strike1.00
Expiry date2023-07-21
Day's range0.3200 - 0.3200
Contract rangeN/A
Volume10
Open interest107
  • Business Wire

    Senseonics Announces Equity Grants To Employees Under Inducement Plan

    GERMANTOWN, Md., January 05, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it had made equity grants to new employees under its 2019 Inducement Plan (the "Plan") in accordance with NYSE American Company Guide Section 711(a).

  • Business Wire

    Senseonics to Present at the Stifel 2022 Healthcare Conference

    GERMANTOWN, Md., November 09, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel Healthcare Conference in New York, NY.

  • Business Wire

    Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results

    GERMANTOWN, Md., November 08, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended September 30, 2022.